Related Experiment Videos
Cholinergic sensitivity predicts severity of mania.
1Mental Health Care Group, Veterans Affairs Medical Center, Long Beach, CA 90822, USA. sokolski.kenneth_n@long_beach.va.gov
Psychiatry Research
|September 7, 2000
Summary
Pupil sensitivity to pilocarpine, a cholinergic agonist, is linked to mania severity in bipolar disorder. More severe mania requires higher pilocarpine concentrations, suggesting a role for the cholinergic system in mood regulation.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Previous studies indicate altered pupillary constriction to pilocarpine in depressed patients and correlated mood improvement with pupil sensitivity in manic patients.
- Cholinergic system dysregulation is implicated in affective disorders.
Purpose of the Study:
- To investigate the relationship between symptom severity and cholinergic sensitivity in manic patients (bipolar I disorder).
- To determine if pupillary responses can serve as a non-invasive measure of cholinergic function in affective disorders.
Main Methods:
- Infrared pupillometry was used to record pupil responses to pilocarpine eye drops (0-2%) in 20 manic patients.
- Pupil responses were compared to those under cholinergic blockade (tropicamide 0.5%).
- Dose-response curves were analyzed using log-logit transformation to determine ED(50) values, which were correlated with Bech-Rafaelsen mania ratings.
Main Results:
- A linear relationship was found between Bech-Rafaelsen mania ratings and ED(50) values (r=0.48).
- Patients with more severe mania required higher pilocarpine concentrations for a 50% pupil size reduction.
- Pupillary responses demonstrated a dose-dependent relationship with pilocarpine administration.
Conclusions:
- Findings support a role for the cholinergic system in regulating mood states in bipolar disorder.
- Pupillary response to pilocarpine may offer a simple, non-invasive method for assessing cholinergic sensitivity in patients with affective disorders.
- This could aid in understanding and potentially managing mood disorders.